Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v2.4.0.6
Consolidated Balance Sheets (USD $)
Mar. 31, 2013
Dec. 31, 2012
Current assets:    
Cash and cash equivalents $ 92,123 $ 62,296
Account receivable net of allowance for doubtful accounts $61,973 and $46,119, respectively 563,258 834,998
Inventories 1,678,316 1,651,087
Prepaid expenses and other current assets 188,934 121,912
Total current assets 2,522,631 2,670,293
Property and equipment, net 3,371,270 3,333,919
Goodwill 1,026,984 1,026,984
Intangibles, net 176,755 190,894
Deferred financing costs, net 15,766 17,677
Total non-current assets 4,590,775 4,569,474
Total Assets 7,113,406 7,239,767
Current liabilities:    
Account payable 1,467,092 736,279
Accrued expenses and other current liabilities 3,257,023 3,127,817
Accrued interest 364,183 286,382
Notes payable - shareholder 1,099,715 1,099,715
Convertible notes payable, net of debt discount 1,816,562 1,472,152
Deferred income tax 102,022 102,022
Derivative instruments 900,292 919,394
Current portion of long term debt 206,040 181,752
Total current liabilities 9,212,929 7,925,513
Long Term Debt 2,956,565 2,894,579
Shareholders' deficiency    
Common stock, $.001 par value, 100,000,000 shares authorized, 63,142,969 shares issued and outstanding at March 31, 2013, and and December 31, 2012 63,143 63,143
Additional paid-in capital 10,484,611 10,484,611
Accumulated deficit (15,603,842) (14,128,079)
Total shareholders' deficiency (5,056,088) (3,580,325)
Total liabilities and shareholders' deficiency $ 7,113,406 $ 7,239,767